Chaanakya Capital logoCHAANAKYA CAPITAL

Investors

The brain is medicine's last frontier. We invest at its leading edge.

Chaanakya Capital backs early-stage neurotech companies, from non-invasive tools to implanted brain-computer interfaces. The fund is raising now.

Why Chaanakya

  • Specialist, not generalist. We only do neurotech, so we read the science, the regulatory path and the surgical reality before we read the pitch.

  • Clinicians at the table. Dr. Johana C.M. Vega Leonel and Dr. Gerald A. Grant bring clinical and neurosurgical judgment to every decision.

  • Portfolio across the spectrum. Companies span non-invasive, minimally invasive and invasive approaches, from early research to clinical stage.

How to engage

Email hi@chaanakya.capital for the deck and a conversation, or to ask about our low investment minimums. You can also ask about co-investment opportunities alongside the fund.

hi@chaanakya.capital

Accredited investors only

Rule 506(c) offering

This is a Rule 506(c) offering available only to accredited investors. Accredited investor status must be verified before an investment is accepted.

Investing in private early-stage companies involves substantial risk, including loss of the entire investment, illiquidity, and a long investment horizon. There is no assurance of investment results. Nothing on this website is investment, legal or tax advice.

Chaanakya Capital's offering is made under Rule 506(c) of Regulation D and is open only to accredited investors whose status has been verified. Nothing on this website is an offer to sell, or a solicitation of an offer to buy, any security; any offer is made only through the fund's offering documents. Venture investing is high-risk and illiquid.

¹ Markups are unrealized. They include a personal angel investment made before the fund was formed; positions held by the fund also carry markups. Past performance is not indicative of future results.

Relevant questions